Clean area

Who is novosanis

Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology.

Colli Pee Novosanis

Improving the quality of diagnostics by volumetric self-sampling of first-void (first catch) urine

Colli-Pee postal kits for home collection

Improving the quality of home-based urine collection by easy self-sampling, alongside postal packaging

Latest news

Collaborate with us in the fight against the spread of monkeypox

The monkeypox (MPX) outbreak is an evolving global health threat. WHO and the Biden administration have declared the outbreak a global health emergency and public health emergency , respectively. As we have learned from the COVID-19 pandemic, screening and early testing are critical strategies for...

Latest blogpost

HIV prevention and STI detection go hand in hand
Given the disproportionate impact of STIs and HIV on the same populations, more convenient STI testing methods are needed to reach groups at risk. PrEP provides the opportunity to reach people at highest HIV and STI risk, expanding HIV prevention and optimizing STI services. Urine has shown to be a more accepted and effective sample type to detect several STIs.

Upcoming event

AMP 2022 banner

Association for Molecular Pathology 2022 (AMP)

Phoenix, Arizona
We will be at the Association for Molecular Pathology (AMP) 2022 Annual Meeting & Expo, which will take place November 1-5 in Phoenix, Arizona. At the conference, our team can tell you more about the benefits of non-invasive sample types such as urine in oncology and infectious disease testing...